Skip to content

Insider · CIK 0001809204

Keith Lamont Cummings

cfoofficer

Files at PLRX (PLIANT THERAPEUTICS, INC.). First filing Jan 22, 2025, latest Jan 22, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $226k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PLRX: PLIANT THERAPEUTICS, INC.

PLRXOct 9, 2026 · close 1.02

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
PLRXsell 410b5-1
PLIANT THERAPEUTICS, INC.
$226k
20,148 shares
-7%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 23, 2025PLRX
PLIANT THERAPEUTICS, INC.
AGrant or award
Common Stock
+56,650$0.00$0319,258Jan 27, 2025
Jan 23, 2025PLRX
PLIANT THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+113,300$0.00$0113,300Jan 27, 2025
Jan 17, 2025PLRX
PLIANT THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-20,148$11.20$226k262,608Jan 22, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Keith Lamont Cummings: insider trades and track record | InsiderTell